To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles.

1. Comparative genomic hybridization spontaneous abortion. (Published in 2006)

2. Comparing patients' telephone calls after medical and surgical abortions. (Published in 2006)

3. Domestic violence as risk factor for unwanted pregnancy and induced abortion in Mulago Hospital, Kampala, Uganda. (Published in 2006)

4. Estimating clandestine abortion with the confidants method-results from Ouagadougou, Burkina Faso. (Published in 2006)

5. Four percent intrauterine lidocaine infusion for pain management in first-trimester abortions. (Published in 2006)

6. Mifepristone vaginally in an early medical abortion regimen: a pilot study. (Published in 2006)

7. Nurse-led telephone consultation and outpatient local anaesthetic abortion: a pilot project. (Published in 2006)

8. The pathway to induced abortion: women's experiences and general practitioner attitudes. (Published in 2006)

9. Risk factors associated with presenting for abortion in the second trimester. (Published in 2006)

10. Sexual abuse and reproductive health among unmarried young women seeking abortion in China. (Published in 2006)

11. The economics of abortion access in the US. Restrictions on government funding for abortion is the post-Roe battleground. (Published in 2006)

12. Determinants of physician unwillingness to offer medical abortion using mifepristone. (Published in 2006)

13. Inherited thrombophilia in recurrent spontaneous abortion among Chinese women. (Published in 2006)

14. Management of first trimester spontaneous abortion with 800 or 400 ug vaginal misoprostol. (Published in 2006)

15. Mandating parental involvement in adolescents' abortion: implications of a short-sighted policy [editorial] (Published in 2006)

16. Patient costs for medication abortion: results from a study of five clinical practices. (Published in 2006)

17. Sublingual versus vaginal route of misoprostol for cervical ripening prior to surgical termination of first trimester abortions. (Published in 2006)

18. Vaginal vs. oral misoprostol for mid-trimester abortion. (Published in 2006)

19. Abortion disclosure and the association with domestic violence. (Published in 2005)

20. Abortion in the moral world of the Cameroon grassfields. (Published in 2005)

21. Abortion practice in the northeast Caribbean: "Just write down stomach pain." (Published in 2005)

22. Abortion procedures in a tertiary care institution in India. (Published in 2005)

23. The acceptability of home medical abortion to women in UK settings. (Published in 2005)

24. Advanced practice clinicians' interest in providing medical abortion: results of a California survey. (Published in 2005)

25. Advanced provision of emergency contraception to postnatal women in China makes no difference in abortion rates: a randomized controlled trial. (Published in 2005)

26. Attitudes of obstetrics and gynecology residents toward abortion participation: a Philadelphia area survey. (Published in 2005)

27. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives. (Published in 2005)

28. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India. (Published in 2005)

29. Cervical priming with sublingual misoprostol vs. 15-methyl-prostaglandin F2 alpha prior to surgical abortion. (Published in 2005)

30. Characteristics of women undergoing repeat induced abortion. (Published in 2005)

31. Client satisfaction with abortion care in three Russian cities. (Published in 2005)

32. Comparison of gemeprost and vaginal misoprostol in first trimester mifepristone-induced abortion. (Published in 2005)

33. Consultations concerning contraception and induced abortions among university students -- trends in Finland 1986-2003. (Published in 2005)

34. Contraception or abortion? Inaccurate descriptions of emergency contraception in newspaper articles, 1992-2002. (Published in 2005)

35. Deprivation and variations in teenage conceptions and abortions in England. (Published in 2005)

36. Does dedicated pre-abortion contraception counselling help to improve post-abortion contraception uptake? (Published in 2005)

37. Domestic violence against women seeking induced abortion in China. (Published in 2005)

38. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation. (Published in 2005)

39. Effect of the interpregnancy interval after an abortion on maternal and perinatal health in Latin America. [Efecto del intervalo entre embarazos después de un aborto sobre la salud materna y perinatal en América Latina.] (Published in 2005)

40. Emergency contraception and prevention of induced abortion in India. (Published in 2005)

41. Evaluating abortion-care programs: old challenges, new directions. (Published in 2005)

42. Factors associated with adolescent abortion in a rural area of Bangladesh. (Published in 2005)

43. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. (Published in 2005)

44. Global progress in abortion advocacy and policy: an assessment of the decade since ICPD. (Published in 2005)

45. Improving induced abortion care in Scotland: enablers and constraints. (Published in 2005)

46. Increased contraceptive use one year post-abortion. (Published in 2005)

47. Introducing medical abortion within the primary health system: comparison with other health interventions and commodities. (Published in 2005)

48. Labor induction abortion utilizing trilostane, a 3beta-hydroxysteroid dehydrogenase inhibitor. (Published in 2005)

49. The magnitude of abortion complications in Kenya. (Published in 2005)

50. Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases. (Published in 2005)

51. Medical abortion in rural Tamil Nadu, South India: a quiet transformation. (Published in 2005)

52. Medical abortion: issues of choice and acceptability. (Published in 2005)

53. Medical abortion: the possibilities for introduction in the public sector in South Africa. (Published in 2005)

54. Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study. (Published in 2005)

55. Medical vs. surgical evacuation of first-trimester spontaneous abortion. (Published in 2005)

56. Misoprostol alone for early abortion: an evaluation of seven potential regimens. (Published in 2005)

57. Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: a temporal association. (Published in 2005)

58. Multicenter trial of a simplified mifepristone medical abortion regimen. (Published in 2005)

59. Patient preference in a randomized study comparing medical and surgical abortion at 10-13 weeks gestation. (Published in 2005)

60. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days. (Published in 2005)

61. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. (Published in 2005)

62. Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study. (Published in 2005)

63. A project to improve the quality of abortion services in Moldova. (Published in 2005)

64. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. (Published in 2005)

65. A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion. (Published in 2005)

66. A randomized controlled study comparing 600 versus 1200 micrograms oral misoprostol for medical management of incomplete abortion. (Published in 2005)

67. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. (Published in 2005)

68. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. (Published in 2005)

69. Reasons U.S. women have abortions: quantitative and qualitative perspectives. (Published in 2005)

70. Referral to a national health service-funded abortion clinic. (Published in 2005)

71. The remaining barriers to the use of emergency contraception: perception of pregnancy risk by women undergoing induced abortions. (Published in 2005)

72. Risks of mifepristone abortion in context. (Published in 2005)

73. Safety of mifepristone abortions in clinical use. (Published in 2005)

74. Study supports the introduction of early medical abortion in Turkey. (Published in 2005)

75. Surgical abortion using manual vacuum aspiration under local anaesthesia: a pilot study of feasibility and women's acceptability. (Published in 2005)

76. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion. (Published in 2005)

77. Tumor necrosis factor receptor 1 expression and early spontaneous abortion. (Published in 2005)

78. Unsafe abortion in Tanzania and the need for involving men in postabortion contraceptive counseling. (Published in 2005)

79. Visualising abortion: emotion discourse and fetal imagery in a contemporary abortion debate. (Published in 2005)

80. Women's perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: a qualitative study. [Perspectivas de las mujeres sobre el aborto medicamentoso en México, Colombia, Ecuador y Perú: estudio cualitativo.] (Published in 2005)

81. You can't do that 'round here: a case study of the introduction of medical abortion care at a University Medical Center. (Published in 2005)

82. Regional differences in age patterns of unsafe abortion suggest need for tailored interventions. (Published in 2005)

83. Medical abortion for Australian women: it's time. (Published in 2005)

84. Recent trends in abortion and contraception in 12 countries. (Published in 2005)

85. Promoting prevention to reduce the need for abortion: good policy, good politics. (Published in 2005)

86. The incidence of induced abortion in the Philippines: current level and recent trends. (Published in 2005)

87. Psychological aftermath of abortion [letter] [reply] (Published in 2005)

88. Psychological aftermath of abortion [letter] (Published in 2005)

89. Reframing social justice, feminism and abortion. Isn't it time we combated the bishops' opposition to reproductive rights on our terms? (Published in 2005)

90. Latin America's abortion battles. [Las batallas sobre el aborto en América Latina.] (Published in 2005)

91. Evaluation of the efficacy of mifepristone / misoprostol and methotrexate / misoprostol for medical abortion. (Published in 2005)

92. A rare case of vesicovaginal fistula following illegal abortion [letter] (Published in 2005)

93. Abortion? That's for women! Narratives and experiences of commercial motorbike riders in south-western Uganda. (Published in 2005)

94. Induced abortion in Nigeria: findings from focus group discussion. (Published in 2005)

95. What you need to know. The difference between medical abortion and emergency contraceptive pills. (Published in 2005)

96. Induced abortion in the United States. (Published in 2005)

97. Abortion and postabortion care in Uganda: a report from health care professionals and health facilities. (Published in 2005)

98. Estimates of U.S. abortion incidence in 2001 and 2002. (Published in 2005)

99. Abortion reporting requirements. State policies in brief as of July 1, 2005. (Published in 2005)

100. Bans on 'partial-birth' abortion. State policies in brief as of August 1, 2005. (Published in 2005)

101. Mandatory counseling and waiting periods for abortion. State policies in brief as of August 1, 2005. (Published in 2005)

102. Parental involvement in minors' abortions. State policies in brief as of August 15, 2005. (Published in 2005)

103. Public funding for contraceptive, sterilization and abortion services, FY 1980-2001. National and state tables and figures. (Published in 2005)

104. Reducing unintended pregnancy and unsafe abortion in Uganda. (Published in 2005)

105. Restricting insurance coverage of abortion. State policies in brief as of August 1, 2005. (Published in 2005)

106. Restrictions on postviability abortions. State policies in brief as of July 1, 2005. (Published in 2005)

107. State funding of abortion under Medicaid. State policies in brief as of August 1, 2005. (Published in 2005)

108. Abortion: a major contributor to maternal ill health [editorial] (Published in 2005)

109. Murder charge for abortion doctor divides medical profession in Kenya. (Published in 2005)

110. Abortion and postabortion care: ethical, legal, and policy issues in developing countries. (Published in 2005)

111. Abortion drugs must become WHO essential medicines [editorial] (Published in 2005)

112. Abortion in the United States. (Published in 2005)

113. Abortion, gay rights and politics in Britain and America: a comparison. (Published in 2005)

114. Accessibility and availability of abortion in six European countries. (Published in 2005)

115. Agonism, deliberation, and the politics of abortion. (Published in 2005)

116. Attitudes about medical abortion among Indian women. (Published in 2005)

117. Attitudes and practices of private medical providers towards family planning and abortion services in Nigeria. (Published in 2005)

118. Brazilian obstetrician-gynecologists and abortion: a survey of knowledge, opinions and practices. [Tocoginecólogos brasileños y el aborto: encuesta de conocimientos, opiniones y prácticas obstétricas.] (Published in 2005)

119. Chinese officials accused of forcing abortions in Shandong. (Published in 2005)

120. Deaths associated with medication abortion [letter] (Published in 2005)

121. Debating late abortion: time to tell the truth. (Published in 2005)

122. Decisions denied: women's access to contraceptives and abortion in Argentina. [Decisiones denegadas: acceso de las mujeres a los métodos anticonceptivos y al aborto en Argentina.] (Published in 2005)

123. Development and evaluation of the abortion attributes questionnaire. (Published in 2005)

124. A dualist analysis of abortion: personhood and the concept of self qua experiential subject. (Published in 2005)

125. Fatal infections associated with mifepristone-induced abortion. (Published in 2005)

126. Fetal fibronectin as predictor of successful induction of mid-trimester abortion. (Published in 2005)

127. Generalized anxiety following unintended pregnancies resolved through childbirth and abortion: a cohort study of the 1995 National Survey of Family Growth. (Published in 2005)

128. Home self-administration of misoprostol for medical abortion up to 56 days' gestation. (Published in 2005)

129. Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France. (Published in 2005)

130. Illegal births and legal abortions -- the case of China. (Published in 2005)

131. Increase in obstacles to abortion: the american perspective in 2004. (Published in 2005)

132. An infant who survived abortion and neonatal intensive care. (Published in 2005)

133. Knowledge and attitudes about abortion legislation and abortion methods among abortion clients in Latvia. (Published in 2005)

134. Language matters: legislation, medical practice, and the classification of abortion procedures. (Published in 2005)

135. Meanings of being pregnant and having decided on abortion: young Swedish women's experiences. (Published in 2005)

136. Medical abortion: a fact sheet. (Published in 2005)

137. Medical abortion: expanding access to safe abortion and saving women's lives. Consensus statement: Medical Abortion: An International Forum on Policies, Programmes and Services, 17-20 October 2004, Johannesburg, South Africa. (Published in 2005)

138. Mifepristone in abortion care. (Published in 2005)

139. Misoprostol as an adjunctive medication in late surgical abortion. (Published in 2005)

140. An outpatient regimen of combined oral mifepristone 400 micrograms and misoprostol 400 micrograms for first-trimester legal medical abortion. (Published in 2005)

141. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone. (Published in 2005)

142. Reasons for induced abortion and their relation to women's emotional distress: a prospective, two-year follow-up study. (Published in 2005)

143. Religion and abortion attitudes among U.S. Hispanics: findings from the 1990 Latino National Political Survey. (Published in 2005)

144. Risk factors for complications of induced abortions in Nigeria. (Published in 2005)

145. Risks of mifepristone abortion in context [letter] (Published in 2005)

146. Romania still faces high abortion rate 16 years after fall of Ceausescu. (Published in 2005)

147. Safe induced abortion -- Is it truly safe with existing health facilities in India? (Published in 2005)

148. Second trimester abortion using intravaginal misoprostol. (Published in 2005)

149. Septic shock after medical abortions with mifepristone (mifeprex, RX 486) and misoprostol. (Published in 2005)

150. Sex selection and fertility in a dynamic model of conception and abortion. (Published in 2005)

151. Sexual behavior and recurrent spontaneous abortion. [Conducta sexual y aborto espontáneo recurrente.] (Published in 2005)

152. Swedish teenager perceptions of teenage pregnancy, abortion, sexual behaivor, and contraceptive habits - a focus group study among 17-year-old female high-school students. (Published in 2005)

153. Theory-based identification of barriers to quality improvement: induced abortion care. (Published in 2005)

154. Trends in abortion in Iran: 1994-2002. (Published in 2005)

155. Using human rights principles to promote quality of abortion care in Brazil. [Invocación de los principios de derechos humanos para promover la calidad de la atención del aborto en Brasil.] (Published in 2005)

156. Views of midwives and gynecologists on legal abortion -- a population-based study. (Published in 2005)

157. Violence and abortions: what's a doctor to do? (Published in 2005)

158. Which factors influence the number of gemeprost pessaries used in inducing second-trimester abortions? (Published in 2005)

159. Why medical abortion is important for women [editorial] (Published in 2005)

160. Willing and able? Provision of medication for abortion by future internists. (Published in 2005)

161. Induced abortion among women attending antenatal clinics in Yaounde, Cameroon. [L'avortement provoqué chez les femmes fréquentant des services de consultation prénatale à Yaoundé, Cameroun.] (Published in 2004)

162. Attitudes and intentions of future health care providers toward abortion provision. (Published in 2004)

163. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. (Published in 2004)

164. Abortion as a backup method for contraceptive failure in China. (Published in 2004)

165. The abortion assessment project--India: key findings and recommendations. (Published in 2004)

166. Abortion law in Nepal: the road to reform. (Published in 2004)

167. Abortion law reform in Nepal: women's right to life and health. (Published in 2004)

168. Abortion law reform in sub-Saharan Africa: no turning back. (Published in 2004)

169. Abortion law, policy and services in India: a critical review. (Published in 2004)

170. Abortion providers and safety of abortion: a community-based study in a rural district of Tamil Nadu, India. (Published in 2004)

171. Abortion, race, and gender in nineteenth-century America. (Published in 2004)

172. Abortion-related maternal mortality in the Russian Federation. (Published in 2004)

173. Abortion: the legal right has been won, but not the moral right. (Published in 2004)

174. Acceptability of home-use of misoprostol in medical abortion. (Published in 2004)

175. Acceptance of contraceptives among women who had an unsafe abortion in Dar es Salaam. (Published in 2004)

176. Accounting for time: insights from a life-table analysis of the efficacy of medical abortion. [La importancia del tiempo: detalles de un análisis de una tabla de vida acerca de la eficacia de los abortos médicos.] (Published in 2004)

177. Adrenomedullin and nitric oxide synthase at the maternal-decidual interface in early spontaneous abortion. (Published in 2004)

178. Advanced practice clinicians as abortion providers: current developments in the United States. (Published in 2004)

179. Advanced provision of emergency contraception does not reduce abortion rates. (Published in 2004)

180. Advocacy for reform of the abortion law in Nigeria. (Published in 2004)

181. Age patterns of unsafe abortion in developing country regions. (Published in 2004)

182. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. (Published in 2004)

183. Are partners available for post-abortion contraceptive counseling? A pilot study in a Baltimore City clinic. (Published in 2004)

184. An assessment of abortion services in public health facilities in Mozambique: women's and providers' perspectives. (Published in 2004)

185. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Collaborative Group on Hormonal Factors in Breast Cancer. (Published in 2004)

186. Cesarean scar dehiscence as a cause of hemorrhage after second-trimester abortion by dilation and evacuation. (Published in 2004)

187. Comparative study between single dose 600 micrograms and repeated dose of oral misoprostol for treatment of incomplete abortion. (Published in 2004)

188. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion. (Published in 2004)

189. Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions. (Published in 2004)

190. Deaths from complications of unsafe abortion: misclassified second trimester deaths. [Muertes por complicaciones de abortos sin condiciones de seguridad: muertes mal clasificadas durante el segundo trimestre.] (Published in 2004)

191. Decision making and referral prior to abortion: a qualitative study of women's experiences. (Published in 2004)

192. Determinants of maternal deaths in induced abortion complications in Ivory Coast. [Déterminants des décès maternels par suite de complications lors d'avortements provoqués en Côte d'Ivoire.] (Published in 2004)

193. Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion. (Published in 2004)

194. Effect of nurses' attitudes on hospital-based abortion procedures in Massachusetts. (Published in 2004)

195. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. (Published in 2004)

196. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study. [Développement de l'avortement médical en Tunisie : expériences de femmes tirées d'une étude de développement multi-site.] (Published in 2004)

197. Family cap provisions and changes in births and abortions. (Published in 2004)

198. From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam. (Published in 2004)

199. History of induced abortion as a risk factor for preterm birth in European countries: results of the EUROPOP survey. (Published in 2004)

200. How research can affect policy and programme advocacy: example from a three-country study on abortion complications in sub-Saharan Africa. (Published in 2004)

201. Improving technologies to reduce abortion-related morbidity and mortality. (Published in 2004)

202. Induced abortion in Thailand: current situation in public hospitals and legal perspectives. (Published in 2004)

203. Infection after medical abortion: a review of the literature. (Published in 2004)

204. Intrauterine lidocaine infusion for pain management in first-trimester abortions. (Published in 2004)

205. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. (Published in 2004)

206. Is induced abortion a contributing factor to tubal infertility in Mexico? Evidence from a case-control study. [¿El aborto inducido es un factor contribuyente a la infertilidad tubárica en México? Evidencia de un estudio de control de casos.] (Published in 2004)

207. Mechanism of recurrent spontaneous abortions in women with mosaicism of X-chromosome aneuploidies. (Published in 2004)

208. The medical abortion experiences of married and unmarried women in Tunis, Tunisia. [L'expérience médicale de l'avortement chez des femmes mariées et célibataires à Tunis, en Tunisie.] (Published in 2004)

209. Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study. (Published in 2004)

210. Methods for induced abortion. (Published in 2004)

211. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. (Published in 2004)

212. Mifepristone-induced abortion and birth weight in the first subsequent pregnancy. (Published in 2004)

213. Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy. (Published in 2004)

214. Misoprostol alone for early medical abortion in a Latin American clinic setting. [Uso exclusivo de misoprostol para inducir abortos medicamentosos tempranos en clínicas de América Latina.] (Published in 2004)

215. Misoprostol as the primary agent for medical abortion in a low-income urban setting. (Published in 2004)

216. Morbidity that is associated with curettage for the management of spontaneous and induced abortion in women who are infected with HIV. (Published in 2004)

217. National laws and unsafe abortion: the parameters of change. (Published in 2004)

218. Peri-abortion contraception: a qualitative study of users' experiences. (Published in 2004)

219. Physician assistants as providers of surgically induced abortion services. (Published in 2004)

220. Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries. [Los conocimientos y opiniones de los médicos acerca del aborto inducido con fármacos en cuatro países de América Latina y de la región del Caribe.] (Published in 2004)

221. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparious Chinese females following surgical abortion. (Published in 2004)

222. Policy implications of a national public opinion survey on abortion in Mexico. [México: repercusión en las políticas de una encuesta nacional de opinión pública sobre el aborto.] (Published in 2004)

223. The political economy of abortion in India: cost and expenditure patterns. (Published in 2004)

224. Prediction of late failure after medical abortion from serial Beta-hCG measurements and ultrasonography. (Published in 2004)

225. Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. (Published in 2004)

226. Pregnancy-associated mortality after birth, spontaneous abortion, or induced abortion in Finland, 1987-2000. (Published in 2004)

227. Prevalence of induced abortion in a reproductive lifetime. (Published in 2004)

228. Prolonged retention of laminaria fragments: a rare complication of induced abortion. (Published in 2004)

229. A randomised controlled trial of a tailored multifaceted strategy to promote implementation of a clinical guideline on induced abortion care. (Published in 2004)

230. Randomised treatment trial of bacterial vaginosis to prevent post-abortion complication. (Published in 2004)

231. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. (Published in 2004)

232. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion. (Published in 2004)

233. Repeat induced abortions and contraceptive practices among unmarried young women seeking an abortion in China. (Published in 2004)

234. Results and lessons learned from a small medical abortion clinical study in Turkey. (Published in 2004)

235. Risk factors for legal induced abortion-related mortality in the United States. (Published in 2004)

236. Routine follow-up visits after first-trimester induced abortion. (Published in 2004)

237. Safe abortion: WHO technical and policy guidance. (Published in 2004)

238. Should doctors be the judges? Ambiguous policies on legal abortion in Nicaragua. [¿Deben juzgar los médicos? Políticas ambiguas sobre el aborto legal en Nicaragua.] (Published in 2004)

239. A strategic assessment of abortion and contraception in Romania. (Published in 2004)

240. Use of contraception and abortion in Greece: a review. (Published in 2004)

241. The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 micrograms in first trimester pregnancies. (Published in 2004)

242. Wellbeing and mental growth -- long-term effects of legal abortion. (Published in 2004)

243. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. II: Side effects and women's perceptions. (Published in 2004)

244. With everything exposed: cruelty in post-abortion care in Rosario, Argentina. [Con todo al aire: crueldad en la atención postaborto en Rosario, Argentina.] (Published in 2004)

245. Yes to abortion but "no" to sexual rights: the paradoxical reality of married women in rural Tamil Nadu, India. (Published in 2004)

246. Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000. 4th ed. (Published in 2004)

247. Abortion and contraception in Romania: a strategic assessment of policy, programme and research issues. Report. (Published in 2004)

248. Estimating the frequency of induced abortion: a comparison of two methods. [Estimativa de aborto induzido: comparaçao entre duas metodologias.] (Published in 2004)

249. Abortion, breast cancer, and the misuse of science. (Published in 2004)

250. The safety of legal abortion and the hazards of illegal abortion. (Published in 2004)

251. Myths and facts about the "Abortion Non-Discrimination Act". (Published in 2004)

252. State refusal clauses for abortion. (Published in 2004)

253. The appropriations process and discriminatory abortion funding restrictions. (Published in 2004)

254. Fertility and abortion: Burmese women's health on the Thai-Burma border. (Published in 2004)

255. Acute pancreatitis following medical abortion: case report. (Published in 2004)

256. My late-term abortion [editorial] (Published in 2004)

257. Socio-economic determinants of induced abortion in China. (Published in 2004)

258. Post abortion care strategy. (Published in 2004)

259. US Justice Department appeals against the rulings that banning partial birth abortion is unconstitutional. (Published in 2004)

260. US House passes bill to protect health providers who won't provide abortions. (Published in 2004)

261. Induced abortion and concurrent adoption of contraception in the rural areas of India (an ICMR Task Force Study) (Published in 2004)

262. Sublingual misoprostol before first trimester abortion: a comparative study using two dose regimens. (Published in 2004)

263. Triaging patients with post-abortion complications: a prospective study in Nepal. (Published in 2004)

264. Abortion and breast cancer [letter] (Published in 2004)

265. Abortion as a method of fertility regulation in Tajikistan. (Published in 2004)

266. Abortion as stigma. More is at stake in the abortion rights backlash than abortion itself. (Published in 2004)

267. Abortion in Brazilian bioethics. [Aborto en bioética brasileña.] (Published in 2004)

268. Abortion pills in Family Welfare Programme? Pitfalls. (Published in 2004)

269. Abortion policy and fertility outcomes: the Eastern European experience. (Published in 2004)

270. Abortion policy and the economics of fertility. (Published in 2004)

271. Abortion surveillance: trends, characteristics and the necessity of data collection. (Published in 2004)

272. Abortion, breast cancer not linked, data say. (Published in 2004)

273. Abortion, health, and the law. (Published in 2004)

274. Abortion: England, Scotland, and Wales. Ethics briefings. (Published in 2004)

275. Abortion: Ethics briefing. (Published in 2004)

276. Abortions and breast cancer: record-based case-control study [letter] (Published in 2004)

277. Abortions common but illegal in Egypt. (Published in 2004)

278. Acceptability of misoprostol at home for voluntary drug-induced abortion. Response of P. Faucher to the article by I. Dagousset et al. (letter) [Enquête d'acceptabilité du misoprostol à domicile pour interruption volontaire de grossesse par méthode médicamenteuse. Réponse de P. Faucher à l'article de I. Dagousset et al.] (Published in 2004)

279. Acceptance rate of HIV testing among women seeking induced abortion in Benin City, Nigeria. (Published in 2004)

280. Access to health care for induced abortions. (Published in 2004)

281. Adolescence and abortion in Greece: women's profile and perceptions. (Published in 2004)

282. Adolescents, unwanted pregnancy and abortion. Policies, counseling and clinical care. (Published in 2004)

283. Advocacy for legal reform for safe abortion. (Published in 2004)

284. Analysing Italian voluntary abortion data using a Bayesian approach to the time series decomposition. (Published in 2004)

285. An appraisal of abortion laws in Southern Africa from a reproductive health rights perspective. (Published in 2004)

286. Assessment of pain associated with medical abortion. (Published in 2004)

287. Audit of abortion and post-abortion care in the UK. (Published in 2004)

288. Bill Baird and the struggle for abortion rights in the USA. (Published in 2004)

289. Breaking the cycle of unsafe abortion in Africa. (Published in 2004)

290. A call for an evidence-based evaluation of late midtrimester abortion [editorial] (Published in 2004)

291. Coercing conscience: the effort to mandate abortion as a standard of care. (Published in 2004)

292. Community-based involvement improves abortion care in rural South Africa. (Published in 2004)

293. Constituency opinion and PAC contributions: a case of the National Abortion and Reproductive Rights Action League. (Published in 2004)

294. Contraceptive behavior of teenagers requesting abortion. (Published in 2004)

295. Contraceptive methods and induced abortions and their association with the risk of colon cancer in Shanghai, China. (Published in 2004)

296. Courts strike "partial-birth" abortion ban; decisions presage future debates. (Published in 2004)

297. The deprivation argument against abortion. (Published in 2004)

298. Desire for a future pregnancy among women in Zimbabwe in relation to their self-perceived risk of HIV infection, child mortality, and spontaneous abortion. (Published in 2004)

299. Destigmatising abortion: expanding community awareness of abortion as a reproductive health issue in Ghana. (Published in 2004)

300. Determinants of induced abortion in Kerala. (Published in 2004)

301. Dialogic framing: The framing/counterframing of "partial-birth" abortion. (Published in 2004)

302. Did legalized abortion lower crime? (Published in 2004)

303. Do prisoners have abortion rights? (Published in 2004)

304. Emergency contraception could lower abortion rate. (Published in 2004)

305. Ensuring women's access to safe abortion care in Latin America and the Caribbean. [Garantizar el acceso a la atención segura del aborto en América Latina y el Caribe.] (Published in 2004)

306. Europe: abortion. (Published in 2004)

307. Family planning in Sweden during 100 years. Abortion and contraceptive agents -- from law-breaking to reproductive right. [Fodelsekontroll i Sverige under 100 Ar. Abort och preventivmedel -- fran lagbrott till reproduktiv rättighet.] (Published in 2004)

308. The federal abortion ban: a clinical and moral dilemma, and international policy setback [editorial] (Published in 2004)

309. Feminist discourse on sex screening and selective abortion of female foetuses. (Published in 2004)

310. Formal and informal abortion services in Rajasthan, India: results of a situation analysis. (Published in 2004)

311. Further evidence that legalized abortion lowered crime. A reply to Joyce. (Published in 2004)

312. The Global Gag Rule and maternal deaths due to unsafe abortion. (Published in 2004)

313. How could the number of abortions in France be reduced? Response of E. Aubény to I. Nisand editorial (letter) [Comment diminuer le nombre des IVG en France? Réponse de E. Aubény a l'éditorial de I. Nisand.] (Published in 2004)

314. Impact of post-abortion counselling in a semi-urban town of Western Nigeria. (Published in 2004)

315. Increased risk for medical abortion failure for multiparous women. (Published in 2004)

316. Induced abortion and effecting factors of ever married women in the Southeast Anatolian Project Region, Turkey: a cross sectional study. (Published in 2004)

317. Induced abortion in Sri Lanka. (Published in 2004)

318. Induced abortion: an overview for internists. (Published in 2004)

319. Induced abortion: an overview for internists. (Published in 2004)

320. International commitments and guidance on unsafe abortion. (Published in 2004)

321. Introduction of post-abortion care in a conservative context: the case of Niger. [Introduction des soins post-avortement dans un contexte conservateur : le cas du Niger.] (Published in 2004)

322. Knowledge, behaviour and attitudes on induced abortion and family planning among Sri Lankan women seeking termination of pregnancy. (Published in 2004)

323. Late sequelae of induced abortion [letter] (Published in 2004)

324. Late sequelae of induced abortion [letter] (Published in 2004)

325. Late sequelae of induced abortion. In response [letter] (Published in 2004)

326. Legal abortion in Nepal and women in prison. (Published in 2004)

327. Lives worth saving: abortion care in sub-Saharan Africa since ICPD. A progress report. (Published in 2004)

328. Maternal grief after abortion and related factors. (Published in 2004)

329. Measuring induced abortion in Mexico. A comparison of four methodologies. [Medición del aborto inducido en México. Comparación de cuatro métodos.] (Published in 2004)

330. Medical abortion in combination with laminaria for first-trimester termination of pregnancy. (Published in 2004)

331. Medical abortion: the Tunisian experience. [Avortement médical : Cas de la Tunisie.] (Published in 2004)

332. Medical methods for first trimester abortion. (Published in 2004)

333. Medical and "surgical" abortion: rethinking the modifiers. (Published in 2004)

334. Mifepristone for medical abortion. (Published in 2004)

335. Misoprostol wetting with acetic acid for pre-abortion cervical priming. (Published in 2004)

336. Nepalese women flock to newly opened abortion clinic. (Published in 2004)

337. Party, constituency, and representation: votes on abortion in the British House of Commons. (Published in 2004)

338. Policy voting in senate elections: the case of abortion. (Published in 2004)

339. Post-viability abortion bans and the limits of the health exception. (Published in 2004)

340. The power dynamics perpetuating unsafe abortion in Africa: a feminist perspective. (Published in 2004)

341. The prevalence of positive anticardiolipin antibody in Jamaican women with spontaneous abortion and the correlation with past clinical history. (Published in 2004)

342. The problem of abortion: essentially contested concepts and moral autonomy. (Published in 2004)

343. A prospective study of induced abortion and breast cancer in African-American women. (Published in 2004)

344. Protection in eye of beholder. Courts send mixed messages about the sanctity of medical files in the face of federal subpoenas for patients' abortion records. (Published in 2004)

345. Provision of abortion services by midwives in Limpopo province of South Africa. (Published in 2004)

346. Psychological impact on women of miscarriage versus induced abortion: a 2-year follow-up study. (Published in 2004)

347. Psychological stress response after miscarriage and induced abortion [letter] (Published in 2004)

348. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion. (Published in 2004)

349. Reducing maternal mortality from unsafe abortion among adolescents in Africa. (Published in 2004)

350. Relevance of lunar periodicity in human spontaneous abortions. (Published in 2004)

351. Response to "Abortions and Breast Cancer: Record-Based Case-Control Study" by Brind and Chinchilli [letter] (Published in 2004)

352. The role of medical imaging in the abortion debate [editorial] (Published in 2004)

353. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting. (Published in 2004)

354. Row brews over Italian abortion proposals. (Published in 2004)

355. A score for measurement of the role of social vulnerability in decisions on abortion. (Published in 2004)

356. Sex selective abortions-pre-birth elimination of girls. (Published in 2004)

357. Social and cultural determinants of attitudes toward abortion: a test of Reiss' hypotheses. (Published in 2004)

358. Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortion. (Published in 2004)

359. Spontaneous abortion through the bladder. (Published in 2004)

360. Stop efforts to gag Title X family planning providers and override the federal Hyde amendment. Oppose the sweeping Abortion 'Non-Discrimination' Act (ANDA) (Published in 2004)

361. Strategies used by low-income Mexican women to deal with miscarriage and "spontaneous" abortion. [Estrategias utilizadas por mujeres mexicanas de bajos recursos para afrontar el aborto y el aborto "espontáneo".] (Published in 2004)

362. Sublingual misoprostol for second-trimester abortion. (Published in 2004)

363. Swept into the back streets. Powerful Christian lobbies are refusing to accept realities about abortion across Africa. (Published in 2004)

364. Transvaginal ultrasound and the success of medical abortion. (Published in 2004)

365. Ultrasound: a window to the womb?: Obstetric ultrasound and the abortion rights debate. (Published in 2004)

366. Understanding induced abortion: findings from a programme of research in Rajasthan, India. (Published in 2004)

367. Uneasy allies: pro-choice physicians, feminist health activists and the struggle for abortion rights. (Published in 2004)

368. Unintended pregnancy and induced abortion among unmarried women in China: a systematic review. (Published in 2004)

369. Unsafe abortion and maternal mortality: is Africa prepared to face the reality? [editorial] (Published in 2004)

370. Unsafe abortion in Uruguay. [Abortos inseguros en Uruguay.] (Published in 2004)

371. Untitled: the abortion pastels: Paula Rego's series on abortion. (Published in 2004)

372. Unwanted pregnancy and induced abortion in Rajasthan, India: a qualitative exploration. (Published in 2004)

373. Unwanted pregnancy and induced abortion: data from men and women in Rajasthan, India. (Published in 2004)

374. US judges seek medical records in abortion cases. (Published in 2004)

375. Use of emergency contraception could halve induced abortion rate in Shanghai, China. (Published in 2004)

376. Use of Misoprostol for medical abortion: a trial of the acceptability for home use. [Enquête d'acceptabilité du misoprostol à domicile pour interruption volontaire de grossesse par méthode médicamenteuse.] (Published in 2004)

377. Victory and beyond: a historical comparative analysis of the outcomes of the abortion movements in Sweden and the United States. (Published in 2004)

378. A woman-centered model for comprehensive abortion care. (Published in 2004)

379. Woman-centred safe abortion care in Africa. (Published in 2004)

380. Women's experiences in connection with induced abortion -- a feminist perspective. (Published in 2004)

381. The accessibility of abortion services in the United States, 2001. (Published in 2003)

382. Abortion incidence and services in the United States in 2000. (Published in 2003)

383. Abortion beliefs and practices among midwives (parteras) in a rural Mexican township. [Creencias y prácticas asociadas al aborto entre las parteras de un municipio rural mexicano.] (Published in 2003)

384. Abortion law reform advocacy in Thailand. (Published in 2003)

385. Abortion service provision in South Africa three years after liberalization of the law. (Published in 2003)

386. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. (Published in 2003)

387. Acceptability of manual versus electric aspiration for first trimester abortion: a randomized trial. (Published in 2003)

388. Adolescents' decision-making and attitudes towards abortion in north-east Brazil. [Toma de decisiones y actitudes de los adolescentes hacia el aborto en el noreste de Brasil.] (Published in 2003)

389. The American College of Obstetricians and Gynecologists and the evolution of abortion policy, 1951-1973: the politics of science. (Published in 2003)

390. An audit of the management of induced abortion in England and Wales. (Published in 2003)

391. Best practices in surgical abortion. (Published in 2003)

392. Can a busy abortion service cope with a screen-and-treat policy for Chlamydia trachomatis infection? (Published in 2003)

393. Cannula fracture in first trimester abortion: a case report and survey of NAF providers. (Published in 2003)

394. Committee Opinion Number 285, August 2003. Induced abortion and breast cancer risk. (Published in 2003)

395. Does male age affect the risk of spontaneous abortion? An approach using semiparametric regression. (Published in 2003)

396. Early abortion services in the United States: a provider survey. (Published in 2003)

397. The effect of lorazepam on pain and anxiety in abortion. (Published in 2003)

398. The effect of training on the provision of elective abortion: a survey of five residency programs. (Published in 2003)

399. Enhancing resident training in abortion and contraception through hospital-community partnership. (Published in 2003)

400. Estimating induced abortion rates: a review. (Published in 2003)

401. Fetal loss in threatened abortion after embryonic / fetal heart activity. (Published in 2003)

402. Gemeprost versus misoprostol for cervical priming before first-trimester abortion: a randomized controlled trial. (Published in 2003)

403. Induced abortion and risk of subsequent miscarriage. (Published in 2003)

404. Integration of post-abortion care: the role of township medical officers and midwives in Myanmar. (Published in 2003)

405. Management of incomplete abortion in South African public hospitals. (Published in 2003)

406. Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases. (Published in 2003)

407. Medical abortion: defining success and categorizing failures. (Published in 2003)

408. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. (Published in 2003)

409. The need for family planning and safe abortion services among women sex workers seeking STI care in Cambodia. (Published in 2003)

410. Normalizing the exceptional: incorporating the "abortion pill" into mainstream medicine. (Published in 2003)

411. Oral and vaginal misoprostol 800 micrograms every 8 h for early abortion. (Published in 2003)

412. Post-diagnostic abortion in Germany: reproduction gone awry, again? (Published in 2003)

413. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. (Published in 2003)

414. Quality of life following early medical or surgical abortion. (Published in 2003)

415. A randomized clinical trial of prophylaxis for vacuum abortion: 3 versus 7 days of doxycycline. (Published in 2003)

416. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. (Published in 2003)

417. A randomized comparison of propofol and methohexital as general anesthetics for vacuum abortion. (Published in 2003)

418. The relationship of placenta previa and history of induced abortion. (Published in 2003)

419. Reproductive awareness behaviour and profiles of adolescent post abortion patients in Blantyre, Malawi. (Published in 2003)

420. Safe abortion for HIV-positive women with unwanted pregnancy: a reproductive right. (Published in 2003)

421. Similarities in women's perceptions and acceptability of manual vacuum aspiration and electric vacuum aspiration for first trimester abortion. (Published in 2003)

422. Treating incomplete abortion in El Salvador: cost savings with manual vacuum aspiration. [Tratamiento del aborto incompleto en El Salvador: ahorro de costos con vacuoextracción manual.] (Published in 2003)

423. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. (Published in 2003)

424. Women's life cycle and abortion decision in unintended pregnancies. (Published in 2003)

425. Induced abortions: decision-making, provider choice and morbidity experience among rural adolescents in India. (Published in 2003)

426. Abortion and the Democrats [letter] [Les Démocrates et l'avortement] [lettre.] (Published in 2003)

427. House votes to restrict abortions. Bill would ban method foes call "partial birth". (Published in 2003)

428. Russians feel abortion's complications. Used as birth control in Soviet times, practice has led to widespread infertility. (Published in 2003)

429. Senate moves to restrict abortions. Ban on late-term procedure passed. [Le Sénat décide de restreindre l'avortement. Interdiction des procédures de fin de grossesse.] (Published in 2003)

430. The difference between emergency contraception and early abortion options (RU 486) (Published in 2003)

431. Suprise, Mom: I'm a